Published in Gene Therapy Weekly, June 8th, 1998
Researchers from several clinical centers participated in phase I/II studies of intratumoral injection of Allovectin-7 which is an HLA-B7/(beta)2M plasmid DNA/lipid complex. Evan M. Hersh of the Arizona Cancer Center represented the clinical teams and presented study results at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Allovectin-7 (HLA-B7/(beta)2M Plasmid DNA/Lipid Complex) Therapy in Metastatic Malignant Melanoma, Phase II...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.